Andrew Hitron
Impact in
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities
Papers in
-
- Angiogenesis and VEGF in Cancer 2
- Cell death mechanisms and regulation 2
- Natural product bioactivities and synthesis 2
-
- Inflammatory mediators and NSAID effects 2
- Flavonoids in Medical Research 2
- Co-authors
- Zhuo Zhang (6 shared papers)Young‐Ok Son (6 shared papers)Poyil Pratheeshkumar (6 shared papers)Amit Budhraja (7 shared papers)Songze Ding (6 shared papers)Jia Luo (5 shared papers)Xianglin Shi (5 shared papers)Jeong‐Chae Lee (3 shared papers)
- Journals
- Toxicology and Applied Pharmacology (3 papers)PLoS ONE (2 papers)International Journal of Oncology (1 paper)Cancer Research (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesChinaIndia
In The Last Decade
Andrew Hitron
9 papers receiving 804 citations
Peers
Comparison fields: 5 of 93
- Biochemistry 136
- Applied Microbiology and Biotechnology 25
- Cancer Research 123
- Molecular Medicine 42
- Toxicology 28
Countries citing papers authored by Andrew Hitron
This map shows the geographic impact of Andrew Hitron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Hitron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Hitron more than expected).
Fields of papers citing papers by Andrew Hitron
This network shows the impact of papers produced by Andrew Hitron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Hitron. The network helps show where Andrew Hitron may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Hitron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 238 | |
| 2 | 2012 | 144 | |
| 3 | 2013 | 140 | |
| 4 | 2012 | 104 | |
| 5 | 2011 | 83 | |
| 6 | 2010 | 64 | |
| 7 | 2013 | 43 | |
| 8 | 2013 | 6 | |
| 9 | 2011 | 2 |
About Andrew Hitron
Andrew Hitron is a scholar working on Molecular Biology, Pharmacology, Health, Toxicology and Mutagenesis, Biochemistry and Cancer Research, having authored 9 papers that have together received 824 indexed citations. Recurring topics across this work include Phytochemicals and Antioxidant Activities (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Inflammatory mediators and NSAID effects (2 papers), Cell death mechanisms and regulation (2 papers), Cancer, Lipids, and Metabolism (2 papers), Flavonoids in Medical Research (2 papers), Natural product bioactivities and synthesis (2 papers) and Traditional Chinese Medicine Analysis (1 paper). The work is most often cited by research in Biochemistry (136 citations), Applied Microbiology and Biotechnology (25 citations), Cancer Research (123 citations), Molecular Medicine (42 citations) and Toxicology (28 citations). Andrew Hitron has collaborated with scholars based in United States, China and India. Frequent co-authors include Zhuo Zhang, Young‐Ok Son, Poyil Pratheeshkumar, Amit Budhraja, Songze Ding, Jia Luo, Xianglin Shi, Jeong‐Chae Lee, Gang Chen and Xin Wang. Their work appears in journals such as Toxicology and Applied Pharmacology, PLoS ONE, International Journal of Oncology, Cancer Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.